Medicine & Health News

TAU research: Neutralizing a protein may prevent disease caused by food allergies

A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University (TAU) may mark a breakthrough in the treatment of Eosinophilic Esophagitis (EoE), a chronic inflammatory disease of the esophagus caused by food allergies. EoE leads to difficulty swallowing, chest and abdominal pain, and even growth delays in children. Its… Read More

TAU achieves breakthrough in regenerative kidney medicine

Researchers from Tel Aviv University (TAU) and Sheba Medical Center have grown human kidney organoids, a synthetic 3D organ culture, from tissue stem cells in the laboratory, mirroring human fetal kidney development for the first time. The current model has matured and stayed stable for over a half a year. Previous kidney organoids mimicking development… Read More

TAU researchers develop mRNA-based vaccine against deadly bacterium

Researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In the groundbreaking study, the researchers tested the vaccine’s resistance to the virulent pathogen that causes the disease and… Read More

TAU develops bioengineered skin that can speed healing

Researchers from Tel Aviv University (TAU) and Sheba Tel Hashomer Medical Center have developed an innovative bioengineered skin equivalent for grafting in burn victims. The bioengineered skin produced from the patient’s own cells is more stable, robust, and flexible than current treatments, making it easier to handle. In a full-thickness wound model, it achieved wound… Read More

TAU researchers identify neutrophils as a key element in advanced breast cancer

Researchers at Tel Aviv University (TAU) found that immune system cells called neutrophils are recruited by the tumor environment in advanced breast cancer to support tumor progression in the later stages of the disease. They believe that neutrophils, which are unique to the tumor environment, may serve as targets for the development of new drugs and… Read More

AI diagnoses slightly more accurate than those of human physicians, TAU study finds

A new study from Tel Aviv University (TAU) found that diagnoses and treatment recommendations given by AI were more accurate than those of physicians at a Los Angeles virtual urgent care clinic. The study, conducted at Cedars-Sinai Connect, compared recommendations given in about 500 visits of adult patients with relatively common respiratory, urinary, eye, vaginal… Read More

TAU researchers double adult stem cells for bone marrow regeneration

An international research team led by scientists from Tel Aviv University (TAU) and Sheba Medical Center has unveiled an innovative method for activating adult stem cells from human bone marrow, enabling their expansion outside the body for use in bone marrow regeneration and the construction of a new blood and immune system. The findings, published… Read More

TAU researchers use CRISPR to cut a gene from head and neck cancers

Researchers from Tel Aviv University (TAU) used the genetic editing tool CRISPR to cut a single gene from cancer cells of head and neck tumors, which successfully eliminated 50% of the tumors in model animals. This groundbreaking study was led by Dr. Razan Masarwy, MD, PhD, from the lab of Professor Dan Peer. Professor Peer… Read More